Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Prior observational studies had raised cardiovascular safety concerns, and the FDA had mandated the trial in 2015
Although the altered redox balance in cancer contributes to tumor progression, it simultaneously presents a significant therapeutic target
Research-grade MTII is typically prepared as an LPS-free peptide and verified as an endotoxin-free peptide , helping minimize confounding variables in sensitive experimental assays
Direct Meds pricing varies by dosage tier
US$ 24.93
US$ 28.72
US$ 29.49
US$ 20.03
US$ 23.39
